Sign In
Buy OSUR
$4.00
-0.0500 (-1.23%)
At Close: Aug 10, 2026
OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates
07:10pm, Tuesday, 25'th Feb 2025
OraSure Technologies (OSUR) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.22 per share a year ago.
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
08:45am, Friday, 14'th Feb 2025
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certai
OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:00pm, Monday, 27'th Jan 2025
OraSure (OSUR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for January 27th
07:06am, Monday, 27'th Jan 2025
ALNY, HBT, APH, GNTY and OSUR have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2024.
Should Value Investors Buy OraSure Technologies (OSUR) Stock?
10:46am, Thursday, 23'rd Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
New Strong Buy Stocks for January 16th
07:16am, Thursday, 16'th Jan 2025
MRCY, BBCP, OSUR, VIK and IFS have been added to the Zacks Rank #1 (Strong Buy) List on January 16, 2025.
OraSure to Present at the J.P Morgan Healthcare Conference
04:05pm, Tuesday, 07'th Jan 2025
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that m
Are Investors Undervaluing OraSure Technologies (OSUR) Right Now?
11:06am, Tuesday, 07'th Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
08:50am, Tuesday, 07'th Jan 2025
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
07:05am, Tuesday, 07'th Jan 2025
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14
OSUR Stock Rises Following the Acquisition of Sherlock Biosciences
12:11pm, Thursday, 26'th Dec 2024
OraSure announces acquisition of Sherlock Biosciences to strengthen its molecular diagnostics portfolio.
OraSure Technologies Acquires Sherlock Biosciences
04:02pm, Thursday, 19'th Dec 2024
BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today anno
OraSure Technologies: Discounted Assets With An Attractive Free Call Option
01:34pm, Wednesday, 11'th Dec 2024
OraSure Technologies is undervalued, trading below its net current asset value, offering a compelling risk-reward scenario with limited downside risk. The company has a robust balance sheet with no lo
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
07:05am, Monday, 02'nd Dec 2024
BETHLEHEM, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that i
Is OraSure Technologies (OSUR) Stock Undervalued Right Now?
10:41am, Thursday, 28'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
